Delivery Order SPE2DB20D3103-SPE2DB24FP5Z2

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets, with a ceiling value of $9,807.11 and a completion date of July 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is registered in the System for Award Management (SAM.gov). The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the U.S. military's medical needs. The contract is a...
This federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $20,952.43 and is a firm fixed price delivery order with a completion date of May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and is an open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,340.11 and is a firm fixed-price delivery order with a completion date of February 5, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
The federal contract award is for the delivery of VALSARTAN-HCTZ 80-12.5 MG TAB 90S to the Defense Logistics Agency (DLA), a defense agency. The $1,234.78 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 23, 2025, with a completion date of June 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $7,725.05. The contract is a delivery order, with a firm fixed-price pricing type, and has an ultimate completion date of September 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award, valued at $4,296.28, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA), is a delivery order that provides the federal government with Valsartan-HCTZ 320-25 mg tablets. The contract has a firm fixed price and an ultimate completion date of June 26, 2024. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of 4,566,178,053 units of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The delivery order has a ceiling value of $3,327.84 and a completion date of October 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $24,044.29 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of January 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets to the Defense Logistics Agency (DLA), a major defense agency under the Department of Defense. The $1,731.54 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $8,434.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-Hctz 160-12.5 mg tablets in quantities of 90 per bottle. This is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP5Z2
    Delivery Order

This federal contract award is for the supply of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $8,165.16. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is July 22, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 1:22 PM